Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial.

Xiaofeng ChenXiaofeng WuHao WuYanhong GuYang ShaoQianwen ShaoFeipeng ZhuXiao LiXiaofeng QianJun HuFengjiao ZhaoWeidong MaoJing SunJian WangGaohua HanChangxian LiYongxiang XiaPoshita Kumari SeesahaDongqin ZhuHuajun LiJunling ZhangGuoqiang WangXuehao WangXiangcheng LiYongqian Shu

Published in: Journal for immunotherapy of cancer (2021)

NCT03486678.

Keyphrases

open label
papillary thyroid
clinical trial
phase ii
phase iii
phase ii study
squamous cell
study protocol
randomized controlled trial
radiation therapy
squamous cell carcinoma
childhood cancer